CPBTD
BMY icon

Central Pacific Bank - Trust Division’s Bristol-Myers Squibb BMY Stock Holding History

Central Pacific Bank - Trust Division’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$536K Sell
8,584
-3,470
-29% -$219K 0.06% 287
2026
Q2 		$695K Sell
12,054
-930
-7% -$53.4K 0.07% 261
2026
Q1 		$787K Sell
12,984
-363
-3% -$21.2K 0.1% 206
2025
Q4 		$720K Sell
13,347
-1,727
-11% -$83.1K 0.09% 239
2025
Q3 		$680K Sell
15,074
-1,402
-9% -$65.5K 0.08% 238
2025
Q2 		$763K Sell
16,476
-577
-3% -$28.3K 0.1% 216
2025
Q1 		$1.04M Sell
17,053
-571
-3% -$33.3K 0.14% 150
2024
Q4 		$997K Sell
17,624
-711
-4% -$39.7K 0.13% 166
2024
Q3 		$949K Sell
18,335
-304
-2% -$14.3K 0.12% 187
2024
Q2 		$774K Buy
18,639
+1,074
+6% +$48.1K 0.09% 230
2024
Q1 		$931K Buy
+17,565
New +$895K 0.12% 195

Other funds holding BMY

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $404M AUM 16.77% 1-Year Est. Return
RT
Rockland Trust Hanover, Massachusetts $2.61B AUM 14.26% 1-Year Est. Return
AAA
Adams Asset Advisors Dallas, Texas $984M AUM 41.12% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
CP
Castleview Partners Dallas, Texas $228M AUM 13.32% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Central Pacific Bank - Trust Division's BMY Position: Q3 2026 in Review

Central Pacific Bank - Trust Division reduced its Bristol-Myers Squibb (BMY) stake by 29% in Q3 2026, selling an estimated $219K and leaving 8,584 shares worth $536K. The position accounts for 0.06% of the portfolio, ranked #287.

Central Pacific Bank - Trust Division first reported a position in BMY in Q1 2024 and has held it in 11 quarters since. The position peaked at $1.04M in Q1 2025. 129 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Central Pacific Bank - Trust Division held 8,584 shares of Bristol-Myers Squibb worth $536K as of Q3 2026.
  • Central Pacific Bank - Trust Division sold 3,470 Bristol-Myers Squibb shares in Q3 2026, an estimated $219K.
  • Bristol-Myers Squibb made up 0.06% of Central Pacific Bank - Trust Division's portfolio in Q3 2026, its #287 holding.
  • Central Pacific Bank - Trust Division first reported a position in Bristol-Myers Squibb in Q1 2024 and has held it in 11 quarters since.
  • Central Pacific Bank - Trust Division's Bristol-Myers Squibb position peaked at $1.04M in Q1 2025.
  • 129 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q3 2026, filed 6 Oct 2026.